{"References": [{"title": "Combination immunotherapy: Using cancer vaccines to generate antitumor T cells and augment their activity with checkpoint modulators", "authors": "Melero I, Berman DM, Aznar MA, Korman AJ, Gracia JL, Haanen J", "journal": "Clinical Cancer Research", "year": "2015", "volumes": "21", "first page": "3115", "last page": "3124", "DOI": "10.1158/1078-0432.CCR-14-2605"}, {"title": "NK cells and cancer immunotherapy: Implications for NK-cell-mediated check point inhibition", "authors": "Smyth MJ, Ngiow SF, Ribas A, Teng MWL", "journal": "Nature Reviews Clinical Oncology", "year": "2016", "volumes": "13", "first page": "397", "last page": "413", "DOI": "10.1038/nrclinonc.2016.91"}, {"title": "Harnessing the immune system to fight cancer: novel checkpoints and combination therapies", "authors": "Sharma P, Allison JP", "journal": "Cancer Discovery", "year": "2015", "volumes": "5", "first page": "1230", "last page": "1232", "DOI": "10.1158/2159-8290.CD-15-0858"}, {"title": "The role of natural killer cells in cancer immunotherapy", "authors": "Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, Yokoyama WM, Ugolini S", "journal": "Nature Reviews Immunology", "year": "2012", "volumes": "12", "first page": "239", "last page": "252", "DOI": "10.1038/nri3171"}, {"title": "T cell-intrinsic mechanisms of immune evasion in cancer", "authors": "Pardoll DM", "journal": "Nature Reviews Immunology", "year": "2012", "volumes": "12", "first page": "383", "last page": "392", "DOI": "10.1038/nri3250"}, {"title": "Natural killer cells in cancer biology and therapy", "authors": "Vivier E, Ugolini S, Blaise D, Chabannon C, Brossay L", "journal": "Nature Reviews Cancer", "year": "2012", "volumes": "12", "first page": "239", "last page": "252", "DOI": "10.1038/nrc3244"}, {"title": "Cancer immunotherapy: moving beyond current vaccines", "authors": "Rosenberg SA, Yang JC, Restifo NP", "journal": "Nature Medicine", "year": "2004", "volumes": "10", "first page": "909", "last page": "915", "DOI": "10.1038/nm1100"}, {"title": "The biology and underlying mechanisms of cancer immunotherapy: recent advances and challenges", "authors": "Chen DS, Mellman I", "journal": "Nature Immunology", "year": "2013", "volumes": "14", "first page": "651", "last page": "658", "DOI": "10.1038/ni.2640"}, {"title": "Immune checkpoint blockade in cancer therapy: toward combination strategies with curative potential", "authors": "Postow MA, Callahan MK, Wolchok JD", "journal": "Science Translational Medicine", "year": "2015", "volumes": "7", "first page": "280sr4", "last page": "280sr4", "DOI": "10.1126/scitranslmed.aaa3642"}, {"title": "The immune contexture in human tumours: impact on clinical outcome", "authors": "Fridman WH, Pagès F, Sautès-Fridman C, Galon J", "journal": "Nature Reviews Cancer", "year": "2012", "volumes": "12", "first page": "298", "last page": "306", "DOI": "10.1038/nrc3245"}]}